⚙
AI-generated deep summary
by claude@2026-06, 2026-06-24
· read from full text
ⓘ
The paper investigated how endothelial deficiency of the transcription factor GATA6 alters immune signaling in human pulmonary arterial endothelial cells, using siRNA knockdown and pharmacologic inhibition in HPAECs. GATA6 loss significantly downregulated interferon response genes and reduced TLR3 expression, while GATA6 overexpression increased these genes, and TLR3 inhibition abrogated the interferon response in endothelial cells. Conditioned medium from GATA6-deficient HPAECs increased interferon gene expression in pulmonary artery smooth muscle cells, indicating a paracrine endothelial–smooth muscle crosstalk mechanism. The study’s main limitation is that it is an in vitro/translational cell-signaling focus with no in vivo or clinical validation described in the provided text. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Abstract
GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 ( TLR3 ) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response in HPAECs. Furthermore, conditioned medium (CM) from GATA6 -deficient HPAECs upregulated interferon genes in pulmonary artery smooth muscle cells ( HPASMCs ), indicating a paracrine effect. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation. New and Noteworthy We show that endothelial GATA6 is required for proper activation of intracellular TLR3 -interferon signaling in HPAECs. GATA6 loss diminishes interferon pathway responses in endothelial cells while promoting an exaggerated interferon signature in adjacent smooth muscle cells via secreted factors. This work reveals a new GATA6-dependent mechanism governing endothelial–smooth muscle crosstalk in pulmonary vascular disease.
Full text
1,744 characters
· extracted from
oa-html
· click to expand
Abstract
GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 ( TLR3 ) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response in HPAECs. Furthermore, conditioned medium (CM) from GATA6 -deficient HPAECs upregulated interferon genes in pulmonary artery smooth muscle cells ( HPASMCs ), indicating a paracrine effect. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation.
New and Noteworthy
We show that endothelial GATA6 is required for proper activation of intracellular TLR3 -interferon signaling in HPAECs. GATA6 loss diminishes interferon pathway responses in endothelial cells while promoting an exaggerated interferon signature in adjacent smooth muscle cells via secreted factors. This work reveals a new GATA6-dependent mechanism governing endothelial–smooth muscle crosstalk in pulmonary vascular disease.
Full Text Availability
The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.